Feedback / Questions
astegolimab (RG 6149) - Amgen, Roche
Astegolimab: Data readout from P3 ARNASA trial (NCT05595642) for COPD in 2025
(Roche)
-
Feb 1, 2024 -
FY2023 Results
P3 data
•
Chronic Obstructive Pulmonary Disease • Immunology
https://assets.roche.com/f/176343/x/1a564f0bae/irp240201.pdf
Feb 1, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious